In 2008, a group led by Prof. Marcos Tobias-Machado, initiated a research series involving the role of the human epidermal growth factor receptor extracellular domain (HER-2/neu) in patients with prostate cancer. First, in an initial sample of 30 patients, there was found to be a strong...